These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 33764188

  • 1. Competing Causes of Death in Older Adults with Thyroid Cancer.
    Papaleontiou M, Norton EC, Reyes-Gastelum D, Banerjee M, Haymart MR.
    Thyroid; 2021 Sep; 31(9):1359-1365. PubMed ID: 33764188
    [Abstract] [Full Text] [Related]

  • 2. Population-based study evaluating and predicting the probability of death resulting from thyroid cancer and other causes among patients with thyroid cancer.
    Yang L, Shen W, Sakamoto N.
    J Clin Oncol; 2013 Feb 01; 31(4):468-74. PubMed ID: 23270002
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cause-specific mortality after diagnosis of thyroid cancer: a large population-based study.
    Du B, Wang F, Wu L, Wang Z, Zhang D, Huang Z, Gao L, Li Y, Liang C, Li P, Yao R.
    Endocrine; 2021 Apr 01; 72(1):179-189. PubMed ID: 32770440
    [Abstract] [Full Text] [Related]

  • 5. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.
    Mazzaferri EL, Jhiang SM.
    Am J Med; 1994 Nov 01; 97(5):418-28. PubMed ID: 7977430
    [Abstract] [Full Text] [Related]

  • 6. Competing-Risks Model for Predicting the Postoperative Prognosis of Patients with Papillary Thyroid Adenocarcinoma Based on The Surveillance, Epidemiology, and End Results (SEER) Database.
    Bian F, Li C, Han D, Xu F, Lyu J.
    Med Sci Monit; 2020 Jul 25; 26():e924045. PubMed ID: 32710734
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Impact of comorbidity on survival among men with localized prostate cancer.
    Albertsen PC, Moore DF, Shih W, Lin Y, Li H, Lu-Yao GL.
    J Clin Oncol; 2011 Apr 01; 29(10):1335-41. PubMed ID: 21357791
    [Abstract] [Full Text] [Related]

  • 9. Death from thyroid cancer of follicular cell origin.
    Wu HS, Young MT, Ituarte PH, D'Avanzo A, Duh QY, Greenspan FS, Loh KC, Clark OH.
    J Am Coll Surg; 2000 Dec 01; 191(6):600-6. PubMed ID: 11129807
    [Abstract] [Full Text] [Related]

  • 10. Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram.
    Kutikov A, Egleston BL, Wong YN, Uzzo RG.
    J Clin Oncol; 2010 Jan 10; 28(2):311-7. PubMed ID: 19933918
    [Abstract] [Full Text] [Related]

  • 11. Treatment Variation in Older Adults With Differentiated Thyroid Cancer.
    Sutton W, Canner JK, Segev DL, Zeiger MA, Mathur A.
    J Surg Res; 2020 Oct 10; 254():154-164. PubMed ID: 32445931
    [Abstract] [Full Text] [Related]

  • 12. Incidence and Survival in Reproductive-Aged Women with Differentiated Thyroid Cancer: United States SEER 18 2000-2016.
    Douglas EH, Rhoads A, Thomas A, Aloi J, Suhl J, Lycan T, Oleson J, Conway KM, Klubo-Gwiezdzinska J, Lynch CF, Romitti PA.
    Thyroid; 2020 Dec 10; 30(12):1781-1791. PubMed ID: 32394796
    [Abstract] [Full Text] [Related]

  • 13. Population-Based Assessment of Complications Following Surgery for Thyroid Cancer.
    Papaleontiou M, Hughes DT, Guo C, Banerjee M, Haymart MR.
    J Clin Endocrinol Metab; 2017 Jul 01; 102(7):2543-2551. PubMed ID: 28460061
    [Abstract] [Full Text] [Related]

  • 14. Treatment and survival vary by race/ethnicity in patients with anaplastic thyroid cancer.
    Roche AM, Fedewa SA, Shi LL, Chen AY.
    Cancer; 2018 Apr 15; 124(8):1780-1790. PubMed ID: 29409119
    [Abstract] [Full Text] [Related]

  • 15. Providing clinicians and patients with actual prognosis: cancer in the context of competing causes of death.
    Howlader N, Mariotto AB, Woloshin S, Schwartz LM.
    J Natl Cancer Inst Monogr; 2014 Nov 15; 2014(49):255-64. PubMed ID: 25417239
    [Abstract] [Full Text] [Related]

  • 16. Disparities in cause-specific mortality by race and sex among bladder cancer patients from the SEER database.
    Shu TD, Schumacher FR, Conroy B, Ponsky L, Mahran A, Bukavina L, Calaway A, Markt SC.
    Cancer Causes Control; 2023 Jun 15; 34(6):521-531. PubMed ID: 36882598
    [Abstract] [Full Text] [Related]

  • 17. The Benefit of Primary Tumor Surgical Resection in Distant Metastatic Carcinomas of the Thyroid.
    Elsamna ST, Suri P, Mir GS, Roden DF, Paskhover B.
    Laryngoscope; 2021 May 15; 131(5):1026-1034. PubMed ID: 32865854
    [Abstract] [Full Text] [Related]

  • 18. Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013.
    Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM.
    JAMA; 2017 Apr 04; 317(13):1338-1348. PubMed ID: 28362912
    [Abstract] [Full Text] [Related]

  • 19. Optimal Cutoff Age for Predicting Mortality Associated with Differentiated Thyroid Cancer.
    Kim SJ, Myong JP, Suh H, Lee KE, Youn YK.
    PLoS One; 2015 Apr 04; 10(6):e0130848. PubMed ID: 26102084
    [Abstract] [Full Text] [Related]

  • 20. A novel model to predict cancer-specific survival in patients with early-stage uterine papillary serous carcinoma (UPSC).
    Chen L, Liu X, Li M, Wang S, Zhou H, Liu L, Cheng X.
    Cancer Med; 2020 Feb 04; 9(3):988-998. PubMed ID: 31846222
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.